Advertisement
Journal Home
Search for

Volume 35, Issue 2, Pages 314-325 (February 2007)


View previous. 16 of 18 View next.

Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell−cell interaction

Wolfgang Wagnerab, Frederik Weina, Christoph Roderburga, Rainer Saffricha, Anne Fabera, Ulf Krausea, Mario Schuberta, Vladimir Benesc, Volker Ecksteina, Holger Mauld, Anthony D. HoaCorresponding Author Informationemail address

Received 22 June 2006; received in revised form 30 August 2006; accepted 5 October 2006.

Objective

The significant role of direct contact between hematopoietic progenitor cells (HPC) and the cellular microenvironment for maintaining “stemness” has been demonstrated. Human mesenchymal stem cell (MSC) feeder layers represent a surrogate model for this interaction. Specific adhesion molecules are responsible for this cell−cell contact.

Methods

To define cell−cell contact between HPC and MSC, we have studied adhesive interaction of various fractions of HPC by using a novel assay based on gravitational force upon inversion. Adherent and nonadherent cells were separated and further analyzed with regard to gene expression and long-term hematopoietic culture initiating cell (LTC-IC) frequency.

Results

HPC subsets with higher self-renewing capacity demonstrated significantly higher adherence to human MSC (CD34+ vs CD34, CD34+/CD38 vs CD34+/CD38+, slow dividing fraction vs fast dividing fraction). LTC-IC frequency was significantly higher in the adherent fraction than in the nonadherent fraction. Furthermore, genes coding for adhesion proteins and extracellular matrix were higher expressed in the adherent subsets of CD34+ cells (fibronectin 1, cadherin 11, vascular cell adhesion molecule-1, connexin 43, integrin β-like 1, and TGFBI).

Conclusion

In this study we have demonstrated that primitive subsets of HPC have higher affinity to human MSC. The essential role of specific junction proteins for stabilization of cell−cell contact is indicated by their significant higher expression.

a Department of Medicine V, University of Heidelberg, Heidelberg, Germany

b Department of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany

c Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany

d Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany

Corresponding Author InformationOffprint requests to: Anthony D. Ho, M.D., Department of Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

PII: S0301-472X(06)00656-4

doi:10.1016/j.exphem.2006.10.003


View previous. 16 of 18 View next.